Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK in $350 million deal to develop cancer drugs with UK biotech firm
GSK in $350 million deal to develop cancer drugs with UK biotech firm
GSK in $350 million deal to develop cancer drugs with UK biotech firm
Submitted by
admin
on June 2, 2014 - 10:02am
Source:
Yahoo/Reuters
News Tags:
GSK
R&D
cancer
UK
Adaptimmune
Headline:
GSK in $350 million deal to develop cancer drugs with UK biotech firm
Do Not Allow Advertisers to Use My Personal information
